Published in Hepatitis Weekly, June 10th, 2002
Brian Carr, MD, PhD, professor and director of the liver tumor service at the University of Pittsburgh Medical Center, evaluated safety and effectiveness of the novel treatment that emits beta rays via microscopic glass beads delivered by catheter directly into the liver through the hepatic artery.
"Hepatocellular carcinoma, a type of cancer that arises from liver...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly